Lactobacillus gasseri OLL2716 as a probiotic in clarithromycin‐resistant Helicobacter pylori infection

Authors:

Abstract
Backgrounds and Aim:  Clarithromycin (CAM)‐resistant Helicobacter pylori sometimes offers serious problems with eradication by antibiotics. The aim of this study was to determine whether a probiotic can be an alternative therapy in CAM‐resistant Hp infection.Methods:  The effects of Lactobacillus gasseri (strain OLL2716) on the growth of CAM‐susceptible and CAM‐resistant H. pylori and interleukin (IL)‐8 production provoked by these strains were examined by in vitro experiments. Moreover, mice were infected with these CAM‐susceptible or CAM‐resistant H. pylori, and were treated with CAM or L. gasseri.Results:  In vitro experiments demonstrated that L. gasseri inhibited the growth of H. pylori and suppressed H. pylori‐associated IL‐8 production. Such effects were noted in CAM‐resistant and CAM‐susceptible H. pylori. Similarly, in an in vivo model of H. pylori infection, H. pylori colonization was significantly decreased by L. gasseri.Conclusion:  Therefore, L. gasseri was found to act as a probiotic in CAM‐resistant H. pylori infection.

This publication has 16 references indexed in Scilit: